Developer of a cholesterol-lowering medicine designed to prevent blood clots in the heart more effectively than the current medicine. The company's platform technology enables the development of prote...

Healthcare
Copenhagen, Denmark
Founded 2017
14 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$63.9M
Last Round
N/A

Get the full picture

Create a free account to unlock Draupnir Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required